Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
EDIBLE GARDEN AG INC (EDBL)
NASDAQConsumer StaplesAgricultural Farm ProductsSnapshot 2026-11-04
$0.70-5.42%
Close 2026-11-05 · 1-day change
NASDAQConsumer StaplesAgricultural Farm ProductsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for EDBL yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Successful capital raises to fund operations | A primary condition in EDIBLE GARDEN AG INC's published investment case. The stated target is Maintain or increase financing at or above $12M in 2026-Q2. | Intact | No further financing secured or capital allocation worsens | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, early-stage growth story with some cyclical exposure, not a proven durable compounder. The multi-year view has operational progress, but the thesis remains fragile because earnings are loss-making and recent performance is weak.
EDBL is described as cheap versus peers, while the expectations gap is negative and valuation confidence is low. The pricing signal is tagged as justified, with low fragility, but that does not remove the risk tied to weak fundamentals.
Near term, elevated miss risk reflects the company’s small size and recent pattern of missing earnings. Over the multi-year view, RTD nutrition revenue and cut herb sales are growing, and management reports progress on commercialization and retail partnerships. A recent acquisition announcement and a new direct financial obligation add uncertainty around execution and capital needs.
The thesis depends on whether the nutrition platform reaches meaningful commercialization and retail partnerships continue to expand. Near term, weaker employment data could weigh on cyclical names, while strong or weak results from sector bellwethers could strengthen or fade the sector tailwind. Continued Nasdaq compliance also matters, though the evidence on its longer-term business impact is limited.
The 1–3 year view combines real operating progress with loss-making results, volatile management, and elevated near-term execution risk. The thesis remains in a watch state and depends on growth translating into stronger financial performance. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company is addressing Nasdaq listing compliance issues. |
| Intact |
| Nasdaq delisting or failure to meet listing standards |
Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth to support business recovery | A primary condition in EDIBLE GARDEN AG INC's published investment case. The stated target is >= $60.8M revenue in FY27. | Improving | revenue falls below $15.7M in FY26 or fails to grow toward $60.8M in FY27 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-13.95 → $-2.88 · observed estimates
$0.06B → $0.06B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-07-25 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-07-26 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-07-27 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-07-28 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-07-29 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-07-30 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-07-31 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-08-01 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-08-02 | $-15.75 | $60,756,000 | 1 / 1 |
| 2026-08-03 | $-15.75 | $60,756,000 | 1 / 1 |
| 2026-08-04 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-08-05 | $-15.75 | $60,756,000 | 1 / 1 |
| 2026-08-06 | $-15.75 | $60,756,000 | 1 / 1 |
| 2026-08-07 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-08-08 | $-15.75 | $60,756,000 | 1 / 1 |
| 2026-08-09 | $-15.75 | $60,756,000 | 1 / 1 |
| 2026-08-10 | $-15.75 | $60,756,000 | 1 / 1 |
| 2026-08-11 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-08-12 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-08-13 | $-15.75 | $60,756,000 | 1 / 1 |
| 2026-08-14 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-08-15 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-08-16 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-08-17 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-08-18 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-08-19 | $-13.95 | $60,756,000 | 1 / 1 |
| 2026-08-20 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-08-21 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-08-22 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-08-23 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-08-24 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-08-25 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-08-26 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-08-27 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-08-28 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-08-29 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-08-30 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-08-31 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-01 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-02 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-03 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-04 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-05 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-06 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-07 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-08 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-09 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-10 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-11 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-12 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-13 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-14 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-15 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-16 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-17 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-18 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-19 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-20 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-21 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-22 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-23 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-24 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-25 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-26 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-27 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-28 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-29 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-09-30 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-01 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-02 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-03 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-04 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-05 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-06 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-07 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-08 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-09 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-10 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-11 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-12 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-13 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-14 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-15 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-16 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-17 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-18 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-19 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-20 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-21 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-22 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-23 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-24 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-25 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-26 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-27 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-28 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-29 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-30 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-10-31 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-11-01 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-11-02 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-11-03 | $-2.88 | $60,756,000 | 1 / 1 |
| 2026-11-04 | $-2.88 | $60,756,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.